BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Interest Income Expense
BRAIN Biotech AG
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Interest Income Expense
-€2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Interest Income Expense
€60.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Evonik Industries AG
XETRA:EVK
|
Interest Income Expense
-€161m
|
CAGR 3-Years
-145%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
5%
|
|
Covestro AG
XETRA:1COV
|
Interest Income Expense
-€102m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Interest Income Expense
-€3.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-109%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Interest Income Expense
-€51.5m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
See Also
What is BRAIN Biotech AG's Interest Income Expense?
Interest Income Expense
-2m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Interest Income Expense amounts to -2m EUR.
What is BRAIN Biotech AG's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
-11%
Over the last year, the Interest Income Expense growth was -323%. The average annual Interest Income Expense growth rates for BRAIN Biotech AG have been -11% over the past three years .